Crossmark

MIG‐6 is essential for promoting glucose metabolic reprogramming and tumor growth in triple‐negative breast cancer

Crossref DOI link: https://doi.org/10.15252/embr.202050781

Published Online: 2021-03-03

Published Print: 2021-05-05

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

He, Jiabei https://orcid.org/0000-0002-7363-6101
Li, Chien‐Feng https://orcid.org/0000-0002-9527-7576
Lee, Hong‐Jen

Shin, Dong‐Hui

Chern, Yi‐Jye https://orcid.org/0000-0003-3533-5735
Pereira De Carvalho, Bruno

Chan, Chia‐Hsin https://orcid.org/0000-0001-8506-7500
Funding

Funding for this research was provided by:

National Cancer Institute (R01 CA211912)

Susan G. Komen (CCR17480331)

Ministry of Science and Technology, Taiwan (MOST109‐2628‐B‐384‐003)

Health Promotion Administration, Ministry of Health and Welfare (MOHW109‐TDU‐B‐212‐134014)
License Information

Version of Record valid from 2021-03-03
More Information

Publication History

Received: 2020-04-30

Accepted: 2021-02-05

Published: 2021-03-03